Water for Contrast-Induced Nephropathy? A Thirst for Knowledge

Journal of Invasive Cardiology

Volumn 15, Issue 12, 2003, Pages 703-705

  Pate, Gordon E ^a   Webb, John G ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENOSINE; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FENOLDOPAM; GLUCOSE; INFUSION FLUID; SODIUM CHLORIDE; THEOPHYLLINE;

ANGIOCARDIOGRAPHY; BOLUS INJECTION; CLINICAL TRIAL; CONTRAST ASSOCIATED NEPHROPATHY; CREATININE BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG INFUSION; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HUMAN; INTERMETHOD COMPARISON; KIDNEY DISEASE; KIDNEY FUNCTION; NOTE;

CONTRAST MEDIA; CREATININE; FLUID THERAPY; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; RISK FACTORS;

EID: 0348109379     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (50)

1. Bettmann MA, Heeren T, Greenfield A, Goudey C. Adverse events with radiographic contrast agents: Results of the SCVIR Contrast Agent Registry. Radiology 1997;203:611-620.
2. Baker CS. Prevention of radiocontrast-induced nephropathy. Cathet Cardiovasc Intervent 2003;58:532-538.
3. Mintz EP, Gruberg L. Radiocontrast-induced nephropathy and percutaneous coronary intervention: A review of preventive measures. Expert Opin Pharmacother 2003;4:639-652.
4. Cuthan GC. Prevention of contrast nephropathy. JAMA 2003;289:606-608.
5. Asif A, Preston RA, Roth D. Radiocontrast-induced nephropathy. Am J Ther 2003;10:137-147.
6. Soma VR, Cavusoglu E, Vidhun R, et al. Contrast-associated nephropathy. Heart Dis 2002;4:372-379.
7. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-2264.
8. Gomes VO, Blaya P, de Figueiredo CE, et al. Contrast-media induced nephropathy in patients undergoing coronary angiography. J Invas Cardiol 2003;15:304-310.
9. Levine GN, Kern MJ, Berger PB, et al. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med 2003;139:123-136.
10. Carver JR. Radiocontrast-induced nephropathy. J Invas Cardiol 2003;15:315-316.
11. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol 2000;11:177-182.
12. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 1995;47:254-261.
13. Barrett BJ, Carlisle EJ. Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171-178.
14. Grines CL, Schreiber TL, Savas V, et al. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996;27:1381-1386.
15. Davidson CJ, Laskey WK, Hetmiller JB, et al. Randomized trial of contrast media utilization in high-risk PTCA: The COURT trial. Circulation 2000;101:2172-2177.
16. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-499.
17. Sarkis A, Badaoui G, Azar R, et al. Gadolinium-enhanced coronary angiography in patients with impaired renal function. Am J Cardiol 2003;91:974-975, A4.
18. Lepor NE. A review of contemporary prevention strategies for radiocontrast nephropathy: A focus on fenoldopam and N-acetylcysteine. Rev Cardiovasc Med 2003;4(Suppl 1):S15-S20.
19. Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 2003;362:598-603.
20. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994;5:125-137.
21. Kellum JA. A drug to prevent renal failure? Lancet 2003;362:589-590.
22. McCullough PA. Beyond serum creatinine: Defining the patient with renal insufficiency and why? Rev Cardiovasc Med 2003;4(Suppl 1):S2-S6.
23. Lindsay J, Apple S, Pinnow EE, et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Cathet Cardiovasc Intervent 2003;59:338-343.
24. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-1548.
25. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study group. Ann Intern Med 1999;130:461-470.
26. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
27. Harmoinen A, Lehtimaki T, Korpela M, et al. Diagnostic accuracies of Plasma Creatinine, Cystatin C, and Glomerular Filtration Rate calculated by the Cockcroft-Gault and Levey (MDRD) formulas. Clin Chem 2003;49:1223-1225.
28. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002;39:920-929.
29. Brinker JA. No CAN? Cather Cardiovasc Intervent 2001;52:417-419.
30. Brinker JA. The third strike. Cathet Cardiovasc Intervent 2002;57:284-285.
31. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375.
32. Bashore TM, Bates ER, Berger PB, et al. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37:2170-2214.
33. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. Am J Roentgenol 1981;136:859-861.
34. Kerstein MD, Puyau FA. Value of periangiography hydration. Surgery 1984;96:919-922.
35. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420.
36. Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 1992;62:413-415.
37. Dudzinski PJ, Petrone AF, Persoff M, Callaghan EE. Acute renal failure following high dose excretory urography in dehydrated patients. J Urol 1971;106:619-621.
38. Weinrauch LA, Robertson WS, D'Elia JA. Contrast media-induced acute renal failure. Use of creatinine clearance to determine risk in elderly diabetic patients. JAMA 1978;239:2018-2019.
39. Teruel JL, Marcen R, Onaindia JM, et al. Renal function impairment caused by intravenous urography. A prospective study. Arch Intern Med 1981;141:1271-1274.
40. Erley CM. Does hydration prevent radiocontrast-induced acute renal failure? Nephrol Dial Transplant 1999;14:1064-1066.
41. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1,620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:329-336.
42. Stevens MA, McCullough PA, Tobin KJ, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999;33:403-411.
43. Taylor AJ, Hotchkiss D, Morse RW, McCabe J. PREPARED: PREParation for Angiography in REnal Dysfunction: A randomized trial of inpatient vs. outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 1998;114:1570-1574.
44. Kamp-Jensen M, Olesen KL, Bach V, et al. Changes in serum electrolyte and atrial natriuretic peptide concentrations, acid-base and haemodynamic status after rapid infusion of isotonic saline and Ringer lactate solution in healthy volunteers. Br J Anaesth 1990;64:606-610.
45. Luft FC, Fineberg NS, Miller JZ, et al. The effects of age, race and heredity on glomerular filtration rate following volume expansion and contraction in normal man. Am J Med Sci 1980;279:15-24.
46. Drummer C, Gerzer R, Heer M, et al. Effects of an acute saline infusion on fluid and electrolyte metabolism in humans. Am J Physiol 1992;262:F744-F754.
47. Erley CM, Duda SH, Rehfuss D, et al. Prevention of radiocontrast-media-induced nephroparhy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 1999;14:1146-1149.
48. Allaqaband S, Tumuluri R, Malik AM, et al. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Cathet Cardiovasc Intervent 2002;57:279-283.
49. Dean LS. Protection from contrast-induced nephropathy: Is the answer in? Cathet Cardiovasc Intervent 2003;58:342-343.
50. Baker CS, Wragg A, Kumar S, et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: The RAPPID study. J Am Coll Cardiol 2003;41:2114-2118.